MetLife Investment Management’s Ategrity Specialty Insurance ASIC Stock Holding History

MetLife Investment Management’s Portfolio ASIC Stock Details ASIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$107K	Buy	+5,402	New	+$105K	﹤0.01%	2508

Other funds holding ASIC

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

MetLife Investment Management's ASIC Position: Q1 2026 in Review

MetLife Investment Management opened a new position in Ategrity Specialty Insurance (ASIC) in Q1 2026: 5,402 shares worth $107K. The stake represents ﹤0.01% of the portfolio and ranks #2508 among its holdings.

87 funds tracked by Wall St. Rank hold ASIC as of Q1 2026.

MetLife Investment Management held 5,402 shares of Ategrity Specialty Insurance worth $107K as of Q1 2026.
Ategrity Specialty Insurance was a new MetLife Investment Management position in Q1 2026.
Ategrity Specialty Insurance made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2508 holding.
87 funds tracked by Wall St. Rank held Ategrity Specialty Insurance as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.